Commerzbank Aktiengesellschaft’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $444K | Sell |
10,410
-6,028
| -37% | -$327K | 0.01% | 268 |
|
|
2026
Q1 | $1.03M | Sell |
16,438
-48,062
| -75% | -$3.84M | 0.02% | 203 |
|
|
2025
Q4 | $6.15M | Buy |
64,500
+49,577
| +332% | +$4.86M | 0.13% | 85 |
|
|
2025
Q3 | $1.46M | Sell |
14,923
-650
| -4% | -$67.3K | 0.03% | 182 |
|
|
2025
Q2 | $1.67M | Sell |
15,573
-190
| -1% | -$19.2K | 0.04% | 142 |
|
|
2025
Q1 | $1.59M | Buy |
15,763
+2,608
| +20% | +$263K | 0.04% | 136 |
|
|
2024
Q4 | $1.18M | Buy |
13,155
+1,498
| +13% | +$132K | 0.03% | 140 |
|
|
2024
Q3 | $977K | Buy |
11,657
+3,177
| +37% | +$250K | 0.03% | 138 |
|
|
2024
Q2 | $654K | Buy |
8,480
+403
| +5% | +$29.5K | 0.02% | 141 |
|
|
2024
Q1 | $554K | Buy |
8,077
+1,758
| +28% | +$113K | 0.02% | 147 |
|
|
2023
Q4 | $366K | Buy |
+6,319
| New | +$337K | 0.01% | 139 |
|
|
2020
Q1 | – | Sell |
-80,942
| Closed | -$3.66M | – | 490 |
|
|
2019
Q4 | $3.66M | Buy |
80,942
+18,373
| +29% | +$769K | 0.04% | 251 |
|
|
2019
Q3 | $2.55M | Buy |
62,569
+6,283
| +11% | +$266K | 0.02% | 395 |
|
|
2019
Q2 | $2.42M | Buy |
56,286
+10,172
| +22% | +$391K | 0.02% | 427 |
|
|
2019
Q1 | $1.77M | Sell |
46,114
-7,073
| -13% | -$270K | 0.02% | 423 |
|
|
2018
Q4 | $1.88M | Buy |
53,187
+22,823
| +75% | +$828K | 0.02% | 424 |
|
|
2018
Q3 | $1.17M | Buy |
30,364
+999
| +3% | +$34.9K | 0.01% | 533 |
|
|
2018
Q2 | $960K | Sell |
29,365
-2,377
| -7% | -$71.7K | 0.01% | 535 |
|
|
2018
Q1 | $867K | Buy |
31,742
+10,967
| +53% | +$298K | 0.01% | 565 |
|
|
2017
Q4 | $515K | Buy |
20,775
+5,209
| +33% | +$144K | 0.01% | 666 |
|
|
2017
Q3 | $454K | Buy |
+15,566
| New | +$430K | 0.01% | 625 |
|
|
2017
Q2 | – | Sell |
-31,506
| Closed | -$784K | – | 724 |
|
|
2017
Q1 | $784K | Buy |
31,506
+8,939
| +40% | +$217K | 0.01% | 526 |
|
|
2016
Q4 | $488K | Buy |
22,567
+5,700
| +34% | +$124K | 0.01% | 619 |
|
|
2016
Q3 | $401K | Sell |
16,867
-18,809
| -53% | -$449K | 0.01% | 631 |
|
|
2016
Q2 | $834 | Sell |
35,676
-4,368
| -11% | -$94.5K | 0.01% | 516 |
|
|
2016
Q1 | $753K | Sell |
40,044
-47,771
| -54% | -$839K | 0.01% | 569 |
|
|
2015
Q4 | $1.62M | Buy |
87,815
+44,248
| +102% | +$793K | 0.01% | 535 |
|
|
2015
Q3 | $715K | Sell |
43,567
-100,383
| -70% | -$1.72M | 0.01% | 664 |
|
|
2015
Q2 | $2.55M | Sell |
143,950
-33,472
| -19% | -$598K | 0.01% | 540 |
|
|
2015
Q1 | $3.15M | Sell |
177,422
-27,675
| -13% | -$437K | 0.02% | 488 |
|
|
2014
Q4 | $2.72M | Sell |
205,097
-220,674
| -52% | -$2.82M | 0.02% | 565 |
|
|
2014
Q3 | $5.03M | Buy |
425,771
+89,675
| +27% | +$1.13M | 0.02% | 485 |
|
|
2014
Q2 | $4.29M | Sell |
336,096
-28,476
| -8% | -$370K | 0.02% | 504 |
|
|
2014
Q1 | $4.93M | Buy |
364,572
+25,680
| +8% | +$337K | 0.02% | 458 |
|
|
2013
Q4 | $4.58M | Sell |
338,892
-148,252
| -30% | -$1.75M | 0.02% | 502 |
|
|
2013
Q3 | $5.72M | Sell |
487,144
-115,339
| -19% | -$1.25M | 0.03% | 434 |
|
|
2013
Q2 | $5.58M | Buy |
+602,483
| New | +$5.11M | 0.02% | 499 |
|
Other funds holding BSX
N
Commerzbank Aktiengesellschaft's BSX Position: Q2 2026 in Review
Commerzbank Aktiengesellschaft reduced its Boston Scientific (BSX) stake by 37% in Q2 2026, selling an estimated $327K and leaving 10,410 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #268.
Commerzbank Aktiengesellschaft first reported a position in BSX in Q2 2013 and has held it in 37 quarters since. The position peaked at $6.15M in Q4 2025. 991 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Commerzbank Aktiengesellschaft held 10,410 shares of Boston Scientific worth $444K as of Q2 2026.
- Commerzbank Aktiengesellschaft sold 6,028 Boston Scientific shares in Q2 2026, an estimated $327K.
- Boston Scientific made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #268 holding.
- Commerzbank Aktiengesellschaft first reported a position in Boston Scientific in Q2 2013 and has held it in 37 quarters since.
- Commerzbank Aktiengesellschaft's Boston Scientific position peaked at $6.15M in Q4 2025.
- 991 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.